- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Tumor necrosis factor ligand superfamily member 15 (TNFSF15), also known as VEGI and TL1A, is a TNF superfamily cytokine involved in endothelial regulation, inflammatory signaling, immune activation, and vascular biology. TNFSF15 Antibody / VEGI Cytokine Antibody recognizes a cytokine-associated signaling protein that contributes to communication between endothelial cells, immune cells, and inflammatory microenvironment pathways.
TNFSF15 antibody, also referred to as VEGI antibody and TL1A antibody in the literature, is useful for studying endothelial-associated cytokine signaling, inflammatory regulation, and immune pathway activation. Clone VEGI/2052R recombinant rabbit monoclonal antibody supports investigation of cytokine-associated signaling mechanisms involved in angiogenesis, immune regulation, and inflammatory disease biology.
TNFSF15 was initially characterized as vascular endothelial growth inhibitor (VEGI) because of reported anti-angiogenic activity in endothelial cell systems. Subsequent studies demonstrated that the cytokine also functions as TL1A, a ligand for death receptor 3 (DR3/TNFRSF25), supporting broader roles in T-cell activation, cytokine amplification, and adaptive immune signaling pathways. Through activation of NFkB and MAPK-associated signaling cascades, TNFSF15 contributes to inflammatory pathway regulation and immune cell communication.
Elevated TNFSF15 expression has been associated with inflammatory bowel disease, rheumatoid arthritis, psoriasis, vascular inflammation, and tumor-associated immune signaling. In endothelial biology research, VEGI/TNFSF15 has also been investigated for its influence on angiogenesis regulation and endothelial proliferation control. The dual endothelial and immunologic functions of TNFSF15 make it a useful target for studies examining interactions between vascular signaling and inflammatory responses.
Analysis of HuProt(TM) protein microarray containing more than 19,000 full-length human proteins identified TNFSF15 as the dominant target recognized by clone VEGI/2052R. The observed Z-score and elevated S-score support highly selective target binding relative to unrelated proteins on the array, supporting utility for cytokine signaling and inflammatory pathway research applications.
Immunohistochemistry staining with TNFSF15 antibodies commonly demonstrates cytoplasmic and extracellular-associated staining patterns within epithelial, endothelial, and inflammatory cellular populations. Because TNFSF15 signaling contributes to both angiogenic and inflammatory pathway regulation, VEGI antibodies remain valuable tools for studying vascular biology, immune signaling, and chronic inflammatory disease mechanisms.
Together, the available immunohistochemistry and protein microarray specificity data support the use of TNFSF15 antibody clone VEGI/2052R for investigating VEGI/TL1A signaling pathways and cytokine-associated inflammatory biology.
For additional TL1A / TNFSF15 / VEGI research antibodies targeting inflammatory cytokine signaling and TNF superfamily immune pathways, explore the broader TL1A Antibody page featuring recombinant rabbit monoclonal clone rVEGI/1283.
Titration of the TNFSF15 Antibody / VEGI Cytokine Antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A full length human recombinant protein was used as the immunogen for this recombinant TNFSF15 antibody.
Store the TNFSF15 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
TNFSF15 antibody, VEGI antibody, TL1A antibody, vascular endothelial growth inhibitor antibody, TNF ligand superfamily member 15 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.